Bo Shu

1.2k total citations
33 papers, 477 citations indexed

About

Bo Shu is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Bo Shu has authored 33 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Bo Shu's work include Liver physiology and pathology (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer-related molecular mechanisms research (3 papers). Bo Shu is often cited by papers focused on Liver physiology and pathology (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer-related molecular mechanisms research (3 papers). Bo Shu collaborates with scholars based in China, Malaysia and Singapore. Bo Shu's co-authors include Chao He, Ruizhi Zhang, Xin Yang, Hao Li, Xinghuan Wang, Sushun Liu, Mimi Zhai, Ping Tan, Yu Xiao and Shaojie Zhuo and has published in prestigious journals such as Scientific Reports, Gene and Sensors and Actuators B Chemical.

In The Last Decade

Bo Shu

28 papers receiving 467 citations

Peers

Bo Shu

SURGE

EPIDE

PRM

Jiancong Chen China

Dong Kyu Kim South Korea

Hui‐Ying Liu China

Chong-Ke Zhao China

Zui Tan China

Yudong Qiu China

Liyan Cui China

Mingchao Ding China

Xinling Li China

Jiancong Chen China

Bo Shu

80 ×0.4

56 ×0.6

133 ×1.5

SURGE

56 ×0.6

EPIDE

72 ×1.2

PRM

Citations per year, relative to Bo Shu Bo Shu (= 1×) peers Jiancong Chen

Countries citing papers authored by Bo Shu

Since Specialization

Citations

This map shows the geographic impact of Bo Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Shu more than expected).

Fields of papers citing papers by Bo Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Shu. The network helps show where Bo Shu may publish in the future.

Co-authorship network of co-authors of Bo Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Shu. A scholar is included among the top collaborators of Bo Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Shu. Bo Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shu, Bo, et al.. (2025). Post-marketing safety signals of imatinib: pharmacovigilance insights from the FDA Adverse Event Reporting System (FAERS) and implications for clinical practice. European Journal of Clinical Pharmacology. 81(9). 1343–1353.

Xu, Jian, Zhen Kang, Xuguang Liu, et al.. (2025). Establishing Clinically Significant Prostate Cancer Diagnosis Models Based on Serum Methylation Levels of Four Genes. Annals of Surgical Oncology. 33(1). 730–739. 1 indexed citations

Shu, Bo, et al.. (2025). Promotion vs. prevention? The impacts of national cultural values and regulatory focus on near-expiry food across Malaysia and China. Food Quality and Preference. 136. 105780–105780.

Shu, Bo, et al.. (2024). TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Cancer Science. 115(5). 1476–1491. 3 indexed citations

Shu, Bo, et al.. (2024). HSPB8-BAG3 chaperone complex modulates cell invasion in intrahepatic cholangiocarcinoma by regulating CASA-mediated Filamin A degradation. Cancer Biology & Therapy. 25(1). 2396694–2396694.

Liu, Xi, et al.. (2023). Macrophage membrane-coated self-assembled curcumin nanoparticle missile for the treatment of colorectal cancer. Journal of Drug Delivery Science and Technology. 91. 105237–105237. 8 indexed citations

Jiang, Hao, Jia Zhao, Ruimin Chang, et al.. (2023). Immunostimulant nanomodulator boosts antitumor immune response in triple negative breast cancer by synergism of vessel normalization and photothermal therapy. Nano Research. 16(8). 11149–11163. 9 indexed citations

Wang, Zhishun, et al.. (2023). Effects of grape seed-derived proanthocyanidin B2 pretreatment on oxidative stress, endoplasmic reticulum stress and apoptosis of renal tubular epithelial cells in renal ischemia–reperfusion injury model of mice. International Urology and Nephrology. 55(10). 2599–2610. 1 indexed citations

Shu, Bo, et al.. (2022). Molecular Mechanisms of Gynostemma pentaphyllum in Prevention and Treatment of Non-Small-Cell Lung Cancer. Evidence-based Complementary and Alternative Medicine. 2022. 1–8. 1 indexed citations

10.

He, Chao, et al.. (2021). The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl4-induced hepatic fibrosis in mice. Life Sciences. 276. 119294–119294. 6 indexed citations

11.

Shu, Bo, et al.. (2021). HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy. Experimental and Molecular Pathology. 123. 104691–104691. 7 indexed citations

12.

Yang, Xin, et al.. (2021). Ppic modulates CCl4-induced liver fibrosis and TGF-β-caused mouse hepatic stellate cell activation and regulated by miR-137-3p. Toxicology Letters. 350. 52–61. 10 indexed citations

13.

Zhai, Mimi, Sushun Liu, Chun Liu, et al.. (2021). The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging. 13(1). 279–300. 31 indexed citations

14.

Zhou, Jiangjiao, Wen‐Hao Chen, Heng Zou, et al.. (2020). Rare postoperative hemorrhage after robotic-assisted pancreatoduodenectomy for pancreatic head cancer: a case report. Journal of Gastrointestinal Oncology. 11(4). 820–825. 2 indexed citations

15.

Zhou, Haihong, Bo Shu, Tong-Zu Liu, et al.. (2018). Association between parity and the risk for urinary incontinence in women. Medicine. 97(28). e11443–e11443. 31 indexed citations

16.

Shu, Bo, Mimi Zhai, Xiongying Miao, et al.. (2018). Serotonin and YAP/VGLL4 Balance Correlated with Progression and Poor Prognosis of Hepatocellular Carcinoma. Scientific Reports. 8(1). 9739–9739. 19 indexed citations

17.

Fang, Yu, Chun Liu, Bo Shu, et al.. (2018). Axis of serotonin -pERK-YAP in liver regeneration. Life Sciences. 209. 490–497. 28 indexed citations

18.

Chen, Liang, Lushun Yuan, Gang Wang, et al.. (2017). Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer. Molecular Medicine Reports. 16(6). 8709–8720. 13 indexed citations

19.

Shu, Bo, et al.. (2015). Short and long-term outcomes after gastrectomy for gastric carcinoma in elderly patients.. PubMed. 8(8). 13578–84. 7 indexed citations

20.

Chen, Peng, et al.. (2012). [Laparoscopic radical cystectomy with orthotopic ileal neobladder in the treatment of invasive bladder cancer].. PubMed. 34(10). 793–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact